VTR
VTR AVD Protein First Chain Second Chain Header View
0.06 0.36 Å 7K4N.pdb B C SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.0 0.46 Å 7BEN.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.01 0.35 Å 7KML.pdb B M CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND View
0.06 1.0 Å 7L2C.pdb B C CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD) View
0.01 0.58 Å 7LS9.pdb C G CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.0 0.4 Å 7DX4.pdb E L THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX View
0.31 1.48 Å 7LQV.pdb C Y CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE View
0.01 0.37 Å 7NXB.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.01 0.37 Å 7NX9.pdb E A CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.02 0.48 Å 6XC2.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 View
0.01 0.39 Å 6XC4.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 View
0.02 0.57 Å 7KXJ.pdb A H SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC View
0.11 0.57 Å 7LD1.pdb A O STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 View
0.04 0.28 Å 7K4N.pdb A L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.04 0.56 Å 7MMO.pdb F E LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.04 0.53 Å 7CWU.pdb A S SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.01 0.44 Å 7CHF.pdb R H CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB View
0.1 0.53 Å 7K8U.pdb B L STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C104 View
0.02 0.41 Å 7BEO.pdb R B CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.06 0.59 Å 7CWM.pdb B G COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE View
0.03 0.5 Å 7KMK.pdb A H CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND View
0.06 0.78 Å 7CWU.pdb A J SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.01 0.51 Å 7CZZ.pdb B I S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B View
0.0 0.41 Å 7EAM.pdb A L IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 View
0.01 0.37 Å 6ZDG.pdb E H ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.07 0.7 Å 7CZQ.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 View
0.01 0.45 Å 7L5B.pdb A H CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-15 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD). View
0.01 0.36 Å 7DPM.pdb C A CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.03 0.68 Å 7CZV.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B View
0.09 0.79 Å 7LOP.pdb A C CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.02 0.46 Å 7CDJ.pdb E L CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1A3 WITH RBD View
0.21 1.47 Å 7LY2.pdb J N SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.02 0.71 Å 7LAB.pdb B X STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 View
0.08 0.52 Å 7M6G.pdb B R STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15 View
0.02 0.43 Å 7K9Z.pdb E A CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 View
0.06 0.69 Å 7CZS.pdb B M S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B View
0.04 0.6 Å 7CWU.pdb C R SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.01 0.5 Å 7KFY.pdb A H STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-F10 FAB) View
0.01 0.37 Å 7NX8.pdb E L CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.01 0.37 Å 7BEP.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.06 0.72 Å 7D4G.pdb B N A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN AGAINST SARS-COV-2 View
0.06 0.33 Å 7K4N.pdb A H SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.03 0.29 Å 7JV2.pdb A L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING MOTIF AND FAB VARIABLE DOMAINS) View
0.0 0.39 Å 7K43.pdb E C SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.09 0.58 Å 7LY2.pdb J O SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.07 1.34 Å 7LQV.pdb B W CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE View
0.06 0.69 Å 7CZQ.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 View
0.0 0.37 Å 7CHF.pdb R B CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB View
0.02 0.36 Å 7KML.pdb A H CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND View
0.05 0.72 Å 7KFW.pdb B D STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) View
0.04 0.47 Å 7JV6.pdb E G SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) View
0.02 0.56 Å 7KFW.pdb A H STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) View
0.05 0.79 Å 6XC4.pdb Z Y CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 View
0.07 1.16 Å 7LQV.pdb B X CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE View
0.02 0.45 Å 7LY2.pdb B F SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.02 0.48 Å 7A29.pdb A D CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION View
0.01 0.59 Å 7KXJ.pdb A L SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC View
0.02 0.35 Å 7BEN.pdb C I CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.0 0.51 Å 7NDA.pdb C L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-253H55L FAB View
0.06 0.77 Å 7M6E.pdb B F STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 View
0.04 0.72 Å 7LM8.pdb A N CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS View
0.04 0.32 Å 7K4N.pdb B D SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.06 0.79 Å 7KFW.pdb A L STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) View
0.02 0.48 Å 7K43.pdb A H SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.03 0.81 Å 7CZU.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B View
0.0 0.39 Å 7KXK.pdb C J SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.03 0.49 Å 7KMG.pdb F D LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.04 0.45 Å 7CWN.pdb A O P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.21 1.38 Å 7LY2.pdb B G SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.01 0.5 Å 7M6H.pdb B F STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 View
0.0 0.39 Å 7BEO.pdb X D CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.03 0.41 Å 7JMW.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB View
0.01 0.42 Å 7A5R.pdb B H COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) View
0.02 0.51 Å 7KFV.pdb B C STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) View
0.01 0.37 Å 7NX9.pdb E H CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.0 0.51 Å 7L5B.pdb A L CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-15 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD). View
0.01 0.45 Å 6XC3.pdb C B CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 View
0.05 0.66 Å 7ND3.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB View
0.03 0.51 Å 7K8W.pdb G S STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 View
0.09 0.78 Å 7CWN.pdb A M P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.0 0.62 Å 7M6E.pdb A G STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 View
0.04 0.75 Å 7KFV.pdb B D STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) View
0.01 0.58 Å 7ND7.pdb C J EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB View
0.01 0.77 Å 7LM8.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS View
0.01 0.32 Å 7L0N.pdb S N CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.01 0.36 Å 7BEP.pdb C G CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.11 0.86 Å 7K8V.pdb A L STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110 View
0.03 0.57 Å 7K8S.pdb B N STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.02 0.37 Å 7C01.pdb B L MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD View
0.01 0.49 Å 6ZDH.pdb B D SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.04 0.19 Å 7JVC.pdb E G SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.01 0.46 Å 6ZER.pdb A C CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.01 0.4 Å 7CAI.pdb A E SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB View
0.02 0.43 Å 6XC3.pdb C L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 View
0.0 0.41 Å 7K43.pdb B H SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.01 0.55 Å 7CZR.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B View
0.0 0.44 Å 6ZER.pdb E H CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.11 0.84 Å 7M6I.pdb A N STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 View
0.05 0.69 Å 7CWM.pdb B J COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE View
0.01 0.42 Å 7A5S.pdb B H COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) View
0.04 0.69 Å 7LD1.pdb C N STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 View
0.02 0.59 Å 7KN6.pdb A C CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3 View
0.01 0.52 Å 7A5R.pdb B I COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) View
0.01 0.45 Å 7A5S.pdb A I COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) View
0.05 0.65 Å 7BEL.pdb X F CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.03 0.73 Å 6XCN.pdb A B STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) View
0.03 0.39 Å 6ZDG.pdb A C ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.03 0.68 Å 7CZV.pdb B I S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B View
0.02 0.3 Å 7KMG.pdb F E LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.04 0.65 Å 7BYR.pdb B H BD23-FAB IN COMPLEX WITH THE S ECTODOMAIN TRIMER View
0.01 0.43 Å 7NDA.pdb C H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-253H55L FAB View
0.01 0.4 Å 7BEK.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 2) View
0.04 0.72 Å 7K8Z.pdb A H STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 View
0.08 1.03 Å 7MF1.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 47D1 View
0.0 0.41 Å 7BEL.pdb X C CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.0 0.49 Å 7ND9.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-253H55L FAB View
0.16 1.59 Å 7K8T.pdb B N STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.01 0.45 Å 7LY2.pdb A F SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.01 0.51 Å 7CZY.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B View
0.02 0.52 Å 7L0N.pdb S D CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.0 0.48 Å 7LXY.pdb J E SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.01 0.65 Å 7A5R.pdb A L COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) View
0.02 0.59 Å 7K8X.pdb B F STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) View
0.01 0.39 Å 7BEL.pdb X E CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.02 0.74 Å 6W41.pdb C H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022 View
0.06 0.33 Å 7K4N.pdb E F SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.02 0.6 Å 7ND7.pdb A H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB View
0.01 0.45 Å 7ND4.pdb B F EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB View
0.0 0.55 Å 7K43.pdb E D SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.03 0.53 Å 7CHC.pdb R A CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB View
0.01 0.36 Å 7BEJ.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 1) View
0.03 0.58 Å 7M6H.pdb C F STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 View
0.04 0.63 Å 7NTC.pdb C L TRIMERIC SARS-COV-2 SPIKE ECTODOMAIN BOUND TO P008_056 FAB View
0.01 0.5 Å 7CZS.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B View
0.0 0.42 Å 7K43.pdb A F SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.01 0.43 Å 6ZER.pdb D F CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.21 1.25 Å 7LM8.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS View
0.02 0.45 Å 7CWS.pdb R G SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.06 0.64 Å 7K90.pdb C O STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 View
0.01 0.5 Å 7K8Z.pdb C M STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 View
0.03 0.5 Å 7CWN.pdb C J P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.09 0.56 Å 7LY2.pdb B I SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.02 0.29 Å 7KMG.pdb F A LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.02 1.05 Å 7DEO.pdb D A CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV View
0.05 0.73 Å 7K8T.pdb C H STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.0 0.4 Å 7CAI.pdb A D SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB View
0.0 0.34 Å 7BEP.pdb E B CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.02 0.52 Å 7KLG.pdb A M SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 View
0.01 0.66 Å 7MMO.pdb F B LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.02 0.37 Å 7KLH.pdb B I SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 View
0.0 0.44 Å 7CAI.pdb B F SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB View
0.01 0.43 Å 6XE1.pdb E H STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A POTENT NEUTRALIZING ANTIBODY, CV30 FAB View
0.03 0.63 Å 7BWJ.pdb E L CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY WITH RBD View
0.02 0.48 Å 7NEH.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB View
0.03 0.49 Å 7BEJ.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 1) View
0.04 0.83 Å 7CZX.pdb B M S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 View
0.02 0.58 Å 7ND7.pdb B F EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB View
0.04 0.25 Å 7JW0.pdb E F SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.0 0.43 Å 7CWS.pdb O H SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.03 0.6 Å 6XC7.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 View
0.0 0.33 Å 7BEN.pdb E A CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.02 0.42 Å 7BEO.pdb X F CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.0 0.72 Å 7MMO.pdb F D LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.0 0.29 Å 7JVA.pdb A L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING DOMAIN AND FAB VARIABLE DOMAINS) View
0.02 0.58 Å 7LXZ.pdb A E SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.02 0.38 Å 7KML.pdb B I CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND View
0.0 0.29 Å 7BEL.pdb X D CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.04 0.59 Å 6XCM.pdb C L STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) View
0.02 0.53 Å 7K43.pdb B C SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.03 0.49 Å 7CWL.pdb C K SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE View
0.08 0.73 Å 7L2E.pdb C I CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.01 0.33 Å 7NEG.pdb E L CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB View
0.0 0.45 Å 7EAM.pdb B D IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 View
0.09 0.61 Å 7LY2.pdb A L SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.03 0.5 Å 7CWN.pdb B I P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.01 0.47 Å 7LXY.pdb B F SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.01 0.34 Å 7KML.pdb C N CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND View
0.05 0.69 Å 7CHF.pdb R L CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB View
0.02 0.59 Å 7CHC.pdb R L CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB View
0.02 0.46 Å 7NDC.pdb A F EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 View
0.0 0.64 Å 7L56.pdb C G CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 View
0.15 1.01 Å 7KFY.pdb A L STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-F10 FAB) View
0.01 0.21 Å 7CHC.pdb R B CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB View
0.02 0.48 Å 7NX8.pdb E B CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.04 0.76 Å 7CZU.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B View
0.0 0.42 Å 7BEO.pdb R L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.01 0.37 Å 6ZFO.pdb E L ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.01 0.35 Å 7M6I.pdb B L STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 View
0.29 1.67 Å 7JV6.pdb E F SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) View
0.04 0.65 Å 7CWM.pdb A L COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE View
0.06 0.89 Å 7D0C.pdb C F S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 View
0.03 0.54 Å 7CAH.pdb A E THE INTERFACE OF H014 FAB BINDS TO SARS-COV-2 S View
0.01 0.5 Å 7DPM.pdb L K CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.01 0.4 Å 6ZFO.pdb E H ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.0 0.38 Å 7K8T.pdb C P STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.04 0.51 Å 7CWO.pdb A H SARS-COV-2 SPIKE PROTEIN RBD AND P17 FAB COMPLEX View
0.03 0.51 Å 7BEK.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 2) View
0.04 0.24 Å 7JW0.pdb B C SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.0 0.43 Å 7DX4.pdb E H THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX View
0.04 0.6 Å 6ZDH.pdb B G SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.1 0.73 Å 7M6I.pdb C L STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 View
0.12 0.88 Å 7K8V.pdb C N STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110 View
0.01 0.51 Å 7CZY.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B View
0.02 0.53 Å 7KXK.pdb B I SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.0 0.48 Å 7NDD.pdb A G EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 View
0.01 0.56 Å 7LXZ.pdb A F SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.25 1.01 Å 7LAA.pdb A H STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1041 View
0.01 0.33 Å 7KMI.pdb C A LY-COV481 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.01 0.39 Å 7CDJ.pdb E H CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1A3 WITH RBD View
0.03 0.66 Å 7K8T.pdb B M STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.02 0.39 Å 7KMG.pdb F B LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.02 0.41 Å 7K8X.pdb C F STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) View
0.0 0.34 Å 7ND7.pdb B G EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB View
0.05 0.83 Å 7LQV.pdb A L CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE View
0.06 0.62 Å 7KMI.pdb C B LY-COV481 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.02 0.55 Å 7K8W.pdb G N STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 View
0.01 0.58 Å 7CZQ.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 View
0.01 0.65 Å 6XCN.pdb A D STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) View
0.04 0.51 Å 7LY3.pdb B E CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB View
0.02 0.4 Å 7BEI.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB View
0.0 0.33 Å 7M3I.pdb C B STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB View
0.07 0.5 Å 7LD1.pdb A P STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 View
0.04 0.68 Å 7LCN.pdb K M STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1 View
0.02 0.46 Å 7NTC.pdb C H TRIMERIC SARS-COV-2 SPIKE ECTODOMAIN BOUND TO P008_056 FAB View
0.0 0.54 Å 7NDD.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 View
0.0 0.59 Å 7M6E.pdb E L STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 View
0.02 0.37 Å 7NDC.pdb C D EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 View
0.04 0.6 Å 7CWU.pdb B N SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.02 0.43 Å 7NDD.pdb C D EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 View
0.01 0.49 Å 7ND8.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 384 FAB View
0.01 0.35 Å 7NEH.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB View
0.03 0.42 Å 7CWO.pdb A L SARS-COV-2 SPIKE PROTEIN RBD AND P17 FAB COMPLEX View
0.03 0.5 Å 7MMO.pdb C B LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.0 0.34 Å 7BEO.pdb R A CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.07 0.72 Å 7D00.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 View
0.0 0.28 Å 7JVA.pdb A H SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING DOMAIN AND FAB VARIABLE DOMAINS) View
0.01 0.39 Å 7K8T.pdb B L STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.01 0.42 Å 7JMO.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-04 View
0.04 0.55 Å 7K8X.pdb A E STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) View
0.0 0.46 Å 7KKL.pdb C B SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 View
0.09 0.78 Å 7CWN.pdb B D P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.01 0.65 Å 6XC3.pdb C H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 View
0.0 0.36 Å 7CHE.pdb R B CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB View
0.01 0.68 Å 7CWM.pdb B L COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE View
0.02 0.68 Å 7LCN.pdb C H STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1 View
0.03 0.64 Å 7K8W.pdb A H STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 View
0.03 0.63 Å 7M6G.pdb B S STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15 View
0.08 0.73 Å 7CHH.pdb C J CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS View
0.07 0.86 Å 7K8S.pdb B P STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.09 0.61 Å 7LXY.pdb A H SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.04 0.62 Å 7CHF.pdb R A CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB View
0.0 0.42 Å 7BEL.pdb R H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.07 0.61 Å 7K90.pdb C P STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 View
0.01 0.43 Å 7ND5.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 150 FAB View
0.01 0.41 Å 7NX6.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.02 0.49 Å 7A5S.pdb A H COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) View
0.05 0.58 Å 7LD1.pdb C M STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 View
0.01 0.47 Å 6ZDH.pdb A H SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.04 0.6 Å 7NX6.pdb E B CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.13 0.9 Å 7LS9.pdb B D CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.06 0.52 Å 7CZT.pdb C I S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 View
0.01 0.52 Å 6XC7.pdb A D CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 View
0.03 0.7 Å 7CAK.pdb C I SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB View
0.05 0.51 Å 7CWN.pdb A G P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.01 0.34 Å 7LXW.pdb A L SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT View
0.03 0.8 Å 6XC4.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 View
0.03 0.7 Å 6XCN.pdb C H STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) View
0.02 0.44 Å 7BEP.pdb E A CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.02 0.49 Å 7JWB.pdb A D SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER View
0.01 0.35 Å 7JWB.pdb B D SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER View
0.05 0.81 Å 7LJR.pdb A S SARS-COV-2 SPIKE PROTEIN TRIMER BOUND TO DH1043 FAB View
0.04 0.8 Å 7CZX.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 View
0.03 0.58 Å 7CAC.pdb B E SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB. View
0.0 0.64 Å 7L56.pdb B K CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 View
0.05 0.58 Å 7CWN.pdb C L P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.0 0.57 Å 7KZB.pdb C L POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES View
0.08 0.61 Å 7K8S.pdb C L STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.01 0.32 Å 7BEN.pdb C D CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.06 0.69 Å 7CZS.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B View
0.01 0.7 Å 7LS9.pdb B F CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.06 0.32 Å 7JVC.pdb A L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.03 0.51 Å 7CAK.pdb A E SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB View
0.06 0.95 Å 7KN5.pdb A E CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U View
0.01 0.43 Å 7A29.pdb C F CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION View
0.01 0.39 Å 7KLH.pdb A H SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 View
0.02 0.41 Å 7KLG.pdb A H SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 View
0.02 0.53 Å 6XC2.pdb Z X CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 View
0.01 0.43 Å 7ND4.pdb C H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB View
0.05 0.54 Å 7CWN.pdb B K P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.06 0.68 Å 7JV6.pdb B D SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) View
0.01 0.62 Å 7JWB.pdb C D SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER View
0.06 0.72 Å 7CZR.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B View
0.01 0.49 Å 6XKP.pdb A M CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 View
0.23 1.05 Å 7L2F.pdb C G CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.0 1.06 Å 7NDB.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 253H165L FAB View
0.05 0.71 Å 7ND6.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB View
0.01 0.5 Å 7A5S.pdb B I COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) View
0.08 0.76 Å 7LOP.pdb Z Y CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.1 0.97 Å 7LXZ.pdb B G SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.02 0.35 Å 7KN5.pdb A D CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U View
0.06 0.47 Å 7M6G.pdb C H STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15 View
0.04 0.59 Å 7CZX.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 View
0.13 1.08 Å 7LM8.pdb A M CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS View
0.0 0.26 Å 6ZER.pdb D C CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.03 0.7 Å 7CZU.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B View
0.01 0.32 Å 7M7W.pdb S B ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.04 0.53 Å 7CHB.pdb R L CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB View
0.02 0.62 Å 7KXJ.pdb C N SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC View
0.1 0.96 Å 7JMW.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB View
0.01 0.39 Å 7DX4.pdb E A THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX View
0.0 0.34 Å 7M7W.pdb S D ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.0 0.42 Å 7LD1.pdb B N STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 View
0.03 0.58 Å 7K8T.pdb A O STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.0 0.46 Å 7L0N.pdb R B CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.03 0.62 Å 7L56.pdb B J CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 View
0.09 0.78 Å 7LJR.pdb A T SARS-COV-2 SPIKE PROTEIN TRIMER BOUND TO DH1043 FAB View
0.02 0.39 Å 7BEN.pdb E B CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.05 0.71 Å 7CZT.pdb A L S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 View
0.19 0.95 Å 7M6F.pdb A H STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22 View
0.02 0.54 Å 6XC7.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 View
0.0 0.4 Å 7A29.pdb A F CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION View
0.07 0.9 Å 7CZP.pdb A L S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 View
0.08 0.7 Å 7L2E.pdb B G CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.02 0.65 Å 7KXK.pdb B J SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.0 0.7 Å 7LXZ.pdb A C SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.01 0.38 Å 7NXB.pdb E A CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.01 0.35 Å 7B3O.pdb E L CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH STE90-C11 FAB View
0.02 0.42 Å 7CAN.pdb B A STRUCTURE OF SYBODY MR17-K99Y IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD) View
0.07 0.66 Å 7CH4.pdb R L CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-604 FAB View
0.01 0.44 Å 7CHB.pdb R H CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB View
0.06 0.56 Å 7K90.pdb B L STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 View
0.01 0.5 Å 7BEH.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB View
0.23 1.04 Å 7L2F.pdb B I CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.0 0.35 Å 7BEO.pdb R H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.03 0.56 Å 7CWS.pdb Q L SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.12 0.89 Å 7LOP.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.01 0.42 Å 7KKL.pdb C E SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 View
0.04 0.39 Å 7M6D.pdb C B STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 View
0.0 0.45 Å 7NDC.pdb C E EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 View
0.04 0.47 Å 7CWN.pdb C H P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.02 0.36 Å 7CAK.pdb C H SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB View
0.1 0.5 Å 7M6F.pdb E D STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22 View
0.06 0.52 Å 7CZT.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 View
0.02 0.71 Å 7LOP.pdb Z B CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.01 0.3 Å 7KLH.pdb B M SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 View
0.08 0.8 Å 7KN7.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3 View
0.06 0.76 Å 7K90.pdb A M STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 View
0.0 0.31 Å 7CAC.pdb A E SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB. View
0.01 0.43 Å 7KMK.pdb B I CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND View
0.04 0.54 Å 7C2L.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8 View
0.03 0.67 Å 7CZV.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B View
0.01 0.34 Å 6ZDG.pdb E L ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.01 0.37 Å 7B3O.pdb E H CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH STE90-C11 FAB View
0.05 0.71 Å 7CZT.pdb C M S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 View
0.05 0.6 Å 7CZX.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 View
0.0 0.38 Å 7KLH.pdb A M SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 View
0.06 0.64 Å 7JV6.pdb A L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) View
0.02 0.56 Å 6XKP.pdb B M CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 View
0.04 0.53 Å 7C2L.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8 View
0.04 0.31 Å 7K4N.pdb E G SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.01 0.38 Å 7NXA.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.0 0.43 Å 7BEP.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.01 0.4 Å 7NX8.pdb E A CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.16 0.96 Å 7LS9.pdb A H CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.01 0.44 Å 7LY3.pdb A D CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB View
0.01 0.43 Å 6ZER.pdb D G CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.05 0.87 Å 7M6E.pdb E D STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 View
0.03 0.59 Å 7CJF.pdb C B CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB View
0.01 0.25 Å 7C8V.pdb B A STRUCTURE OF SYBODY SR4 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD) View
0.02 0.41 Å 7KN7.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3 View
0.01 0.44 Å 7M6D.pdb C A STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 View
0.03 0.66 Å 7CHE.pdb R H CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB View
0.07 0.81 Å 7KFW.pdb E G STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) View
0.07 0.81 Å 7K90.pdb B H STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 View
0.03 0.71 Å 7CZV.pdb B M S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B View
0.01 0.55 Å 7D03.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-2G7 View
0.01 0.31 Å 7K45.pdb B L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS) View
0.02 0.38 Å 6XC2.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 View
0.07 0.95 Å 7LAB.pdb A T STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 View
0.08 0.81 Å 7LY0.pdb A L SARS-COV-2 S/S2M11/S2M28 LOCAL REFINEMENT View
0.01 0.31 Å 7KLH.pdb A L SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 View
0.05 0.95 Å 7LAA.pdb A L STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1041 View
0.04 0.46 Å 7CWN.pdb B E P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.01 0.34 Å 7K8Y.pdb D I STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2) View
0.16 0.99 Å 7LOP.pdb Z X CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.06 0.64 Å 7CWU.pdb B H SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.0 0.69 Å 7LXZ.pdb K D SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.05 0.64 Å 7CWM.pdb C K COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE View
0.0 0.52 Å 7CZZ.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B View
0.0 0.52 Å 7CZZ.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B View
0.05 1.03 Å 6XKQ.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-250 View
0.0 0.74 Å 7K8T.pdb A P STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.0 0.41 Å 7BEL.pdb R A CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.08 0.95 Å 7KN7.pdb A B CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3 View
0.01 0.38 Å 7DPM.pdb F H CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.06 0.6 Å 7K8X.pdb B D STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) View
0.02 0.46 Å 7BWJ.pdb E H CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY WITH RBD View
0.0 0.35 Å 7M7W.pdb R H ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.03 0.32 Å 7CAC.pdb B D SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB. View
0.0 0.32 Å 7KXK.pdb A H SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.0 0.52 Å 7NDD.pdb C E EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 View
0.04 0.67 Å 7LXW.pdb A H SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT View
0.0 0.46 Å 7LXY.pdb A F SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.09 0.67 Å 7LD1.pdb B H STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 View
0.06 0.73 Å 7CHE.pdb R A CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB View
0.06 0.84 Å 7M6E.pdb A H STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 View
0.01 0.42 Å 7KXK.pdb A L SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.17 0.91 Å 7M6F.pdb E C STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22 View
0.01 0.41 Å 7CWS.pdb Q D SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.02 0.58 Å 7LXZ.pdb K M SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.01 0.58 Å 7CZQ.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 View
0.03 0.65 Å 7LXX.pdb A H SARS-COV-2 S/S2M11/S2L28 LOCAL REFINEMENT View
0.02 0.44 Å 7KXK.pdb A N SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.01 0.41 Å 7CHC.pdb R H CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB View
0.17 1.11 Å 7JV4.pdb B D SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN) View
0.02 0.28 Å 6ZDG.pdb A L ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.0 0.39 Å 7LSS.pdb B L CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 7 View
0.02 0.46 Å 7NDD.pdb A F EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 View
0.0 0.43 Å 7LXY.pdb B M SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.0 0.28 Å 7M7W.pdb S A ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.02 0.71 Å 7KFV.pdb E F STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) View
0.02 0.58 Å 7LXZ.pdb B F SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.01 0.32 Å 7BEM.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 SCFV View
0.05 0.61 Å 7LY3.pdb A C CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB View
0.0 0.39 Å 7NDC.pdb A G EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 View
0.03 0.57 Å 7D0D.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_2B View
0.0 0.53 Å 7BEN.pdb E F CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.02 0.55 Å 7DPM.pdb I H CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.08 0.65 Å 7L2E.pdb A H CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.05 0.77 Å 7L56.pdb C F CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 View
0.06 0.58 Å 7CWU.pdb C M SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.03 0.9 Å 7L56.pdb A L CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 View
0.0 0.52 Å 7A5S.pdb A L COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) View
0.02 0.22 Å 7CWL.pdb B L SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE View
0.03 0.49 Å 7DPM.pdb F E CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.02 0.39 Å 7BEM.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 SCFV View
0.01 0.49 Å 7NDD.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 View
0.02 0.49 Å 7JMP.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-39 View
0.04 0.84 Å 7M6H.pdb A E STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 View
0.06 1.08 Å 7L2C.pdb A L CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD) View
0.03 0.5 Å 7KFW.pdb A D STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) View
0.13 0.79 Å 7KN5.pdb B D CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U View
0.09 0.78 Å 7CWN.pdb C N P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.02 0.46 Å 7K8X.pdb A G STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) View
0.06 0.92 Å 7ND4.pdb A E EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB View
0.0 0.66 Å 7LXZ.pdb B L SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.0 0.3 Å 7BEL.pdb R B CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.01 0.54 Å 7LXZ.pdb K E SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.0 0.48 Å 7NDC.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 View
0.01 0.6 Å 7D00.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 View
0.06 0.71 Å 7D00.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 View
0.04 0.66 Å 7K8T.pdb C L STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) View
0.01 0.5 Å 7CZZ.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B View
0.0 0.44 Å 7ND9.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-253H55L FAB View
0.03 0.53 Å 7L3N.pdb B D SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555 View
0.0 0.32 Å 7ND7.pdb A L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB View
0.0 0.33 Å 7KXK.pdb B N SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.13 0.85 Å 7LS9.pdb C E CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.0 0.39 Å 7BEO.pdb X C CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.01 0.29 Å 7L0N.pdb R L CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.05 0.88 Å 7ND4.pdb C L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB View
0.04 0.65 Å 7CWS.pdb O N SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.03 0.56 Å 7D0D.pdb B G S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_2B View
0.01 0.63 Å 7MMO.pdb C E LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.07 0.65 Å 7M6D.pdb C L STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 View
0.01 0.39 Å 7NX9.pdb E L CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.01 0.48 Å 7EAM.pdb A H IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 View
0.05 0.51 Å 7K90.pdb A N STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 View
0.01 0.39 Å 7NXB.pdb E B CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.01 0.33 Å 7NXB.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.04 0.92 Å 7K8S.pdb C N STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.01 0.72 Å 7D03.pdb A L S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-2G7 View
0.01 0.64 Å 7LS9.pdb A L CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.13 1.43 Å 7LQV.pdb C Z CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE View
0.03 0.54 Å 7JMO.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-04 View
0.04 0.49 Å 7KMH.pdb C B LY-COV488 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.01 0.59 Å 7CZX.pdb A N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 View
0.01 0.4 Å 7E23.pdb A B SARS-COV-2 SPIKE IN COMPLEX WITH THE CA521 NEUTRALIZING ANTIBODY FAB (FOCUSED REFINEMENT ON FAB-RBD) View
0.01 0.38 Å 7NX6.pdb E A CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.0 0.29 Å 6ZDH.pdb A D SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.01 0.46 Å 7LY2.pdb J E SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.01 0.51 Å 7CZS.pdb B I S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B View
0.01 0.46 Å 7CDI.pdb E H CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH RBD View
0.01 0.41 Å 7KLG.pdb B I SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 View
0.04 0.65 Å 7L2E.pdb A L CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.06 0.91 Å 7K8S.pdb C M STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.09 1.05 Å 7KMG.pdb C D LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.01 0.35 Å 7DPM.pdb L J CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.05 0.75 Å 7K8Z.pdb A L STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 View
0.05 0.77 Å 7LCN.pdb A B STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1 View
0.01 0.41 Å 7CH5.pdb R H CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB View
0.04 0.8 Å 7L56.pdb A H CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 View
0.01 0.36 Å 7NX7.pdb E H CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.03 0.82 Å 7LAB.pdb A S STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 View
0.02 0.52 Å 7M6D.pdb C H STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 View
0.15 1.11 Å 7M6I.pdb C H STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 View
0.01 0.33 Å 6XDG.pdb E C COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES View
0.09 0.77 Å 7CHE.pdb R L CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB View
0.01 0.56 Å 7CZR.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B View
0.02 0.39 Å 7CAI.pdb B G SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB View
0.0 0.61 Å 7M6E.pdb B C STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 View
0.03 0.55 Å 7ND3.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB View
0.0 0.53 Å 6ZER.pdb A H CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.0 0.35 Å 7BEN.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.01 0.46 Å 6ZFO.pdb A B ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.01 0.29 Å 7K45.pdb B H SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS) View
0.09 0.99 Å 7K8S.pdb A H STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.0 0.33 Å 7NXA.pdb E A CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.01 0.42 Å 7ND6.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB View
0.01 0.47 Å 7NDB.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 253H165L FAB View
0.02 0.32 Å 7KMG.pdb C B LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.0 0.46 Å 7KKL.pdb A F SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 View
0.0 0.54 Å 7A5S.pdb B M COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) View
0.0 0.3 Å 6ZDH.pdb A L SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.01 0.34 Å 7NX7.pdb E A CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.05 0.63 Å 7C01.pdb A L MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD View
0.09 0.9 Å 7LAB.pdb C H STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 View
0.01 0.47 Å 7CAH.pdb A D THE INTERFACE OF H014 FAB BINDS TO SARS-COV-2 S View
0.01 0.42 Å 7KXJ.pdb B M SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC View
0.01 0.37 Å 7M3I.pdb C A STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB View
0.02 0.99 Å 7KZB.pdb C A POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES View
0.08 0.59 Å 7CWS.pdb R F SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.01 0.34 Å 7L0N.pdb R A CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.01 0.67 Å 7KZB.pdb C H POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES View
0.04 0.69 Å 6XCM.pdb B S STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) View
0.02 0.46 Å 7KMK.pdb A L CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND View
0.06 0.81 Å 7KFV.pdb A L STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) View
0.01 0.36 Å 7NEG.pdb E H CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB View
0.0 0.4 Å 7JMP.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-39 View
0.01 0.48 Å 7LXY.pdb A E SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.0 0.35 Å 7BEO.pdb X E CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS View
0.0 0.34 Å 7L0N.pdb S C CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.01 0.41 Å 7CJF.pdb C A CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB View
0.14 1.11 Å 7L2D.pdb A H CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 1-87 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.13 1.09 Å 7LY0.pdb A H SARS-COV-2 S/S2M11/S2M28 LOCAL REFINEMENT View
0.01 0.32 Å 7KXK.pdb C N SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.01 0.45 Å 7KS9.pdb B H CRYO-EM STRUCTURE OF PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH 910-30 FAB View
0.0 0.39 Å 7M6H.pdb A G STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 View
0.08 0.59 Å 7KN5.pdb A C CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U View
0.03 0.67 Å 7CAK.pdb B G SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB View
0.04 0.51 Å 7CWL.pdb A H SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE View
0.03 0.54 Å 7ND8.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 384 FAB View
0.08 1.16 Å 7KN5.pdb B F CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U View
0.05 0.67 Å 7D0C.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 View
0.04 0.52 Å 7DPM.pdb C B CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.02 0.63 Å 6XCN.pdb C L STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) View
0.05 0.56 Å 7CWM.pdb A H COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE View
0.06 0.85 Å 7CWS.pdb R P SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.0 0.55 Å 7K43.pdb B L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.0 0.58 Å 7BYR.pdb B L BD23-FAB IN COMPLEX WITH THE S ECTODOMAIN TRIMER View
0.06 0.84 Å 7M6I.pdb A M STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 View
0.03 0.79 Å 7CWS.pdb O I SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.01 0.36 Å 7KLG.pdb A L SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 View
0.03 0.5 Å 7CWL.pdb B J SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE View
0.0 0.59 Å 7BEP.pdb C I CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.02 0.49 Å 7NX7.pdb E B CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.04 0.61 Å 7CZX.pdb B I S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 View
0.02 0.53 Å 7CWS.pdb Q E SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL View
0.01 0.5 Å 7ND4.pdb A D EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB View
0.05 0.74 Å 7CHH.pdb A D CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS View
0.04 0.51 Å 7CWL.pdb B G SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE View
0.01 0.52 Å 7KXK.pdb B M SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION View
0.11 1.06 Å 7LQV.pdb A H CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE View
0.01 0.43 Å 6ZER.pdb E L CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.01 0.31 Å 7M7W.pdb S C ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.02 0.38 Å 7C8W.pdb B A STRUCTURE OF SYBODY MR17 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR- BINDING DOMAIN (RBD) View
0.01 0.5 Å 7K9Z.pdb E H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 View
0.01 0.46 Å 7LY2.pdb A E SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.02 0.41 Å 6XC2.pdb Z Y CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 View
0.01 0.57 Å 7CZW.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 View
0.01 0.36 Å 7KML.pdb A L CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND View
0.01 0.72 Å 7CZW.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 View
0.01 0.42 Å 7LY2.pdb B M SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.23 1.04 Å 7L2F.pdb A H CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.01 0.41 Å 6ZFO.pdb A C ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.01 0.64 Å 6XCN.pdb E G STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) View
0.02 0.39 Å 7K8Y.pdb B I STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2) View
0.01 0.45 Å 7L0N.pdb R E CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.01 0.47 Å 7LY3.pdb B F CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB View
0.02 0.49 Å 7A5R.pdb A H COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) View
0.03 0.7 Å 7CZV.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B View
0.05 0.5 Å 7CWL.pdb C I SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE View
0.0 0.48 Å 6XKQ.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-250 View
0.0 0.6 Å 7K43.pdb A G SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.04 0.72 Å 6XC3.pdb C A CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 View
0.01 0.37 Å 7KLG.pdb B M SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 View
0.02 0.41 Å 7K9Z.pdb E B CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 View
0.0 0.28 Å 6ZDG.pdb E G ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.01 0.38 Å 7M7W.pdb R E ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.02 0.43 Å 7A29.pdb B E CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION View
0.01 0.42 Å 7MMO.pdb C A LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.01 0.44 Å 7CHH.pdb C K CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS View
0.05 0.63 Å 7CWM.pdb C I COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE View
0.04 0.7 Å 7BEL.pdb R L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS View
0.03 0.75 Å 7JV4.pdb A L SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN) View
0.04 0.53 Å 7C2L.pdb B I S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8 View
0.03 0.48 Å 7CWL.pdb A L SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE View
0.04 0.55 Å 7C01.pdb B D MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD View
0.0 0.54 Å 7CZZ.pdb B M S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B View
0.0 0.29 Å 7L3N.pdb C D SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555 View
0.01 0.49 Å 7K43.pdb E F SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.03 0.51 Å 7CWU.pdb C P SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.07 0.86 Å 7CZP.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 View
0.03 0.81 Å 7CZX.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 View
0.0 0.27 Å 7BEP.pdb C F CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.01 0.36 Å 7C01.pdb B C MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD View
0.02 0.54 Å 6XKP.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 View
0.0 0.44 Å 7KKL.pdb D E SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 View
0.03 0.52 Å 7KXJ.pdb B I SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC View
0.1 0.95 Å 7LOP.pdb Z V CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.01 0.38 Å 6XDG.pdb E B COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES View
0.0 0.31 Å 7BEH.pdb E L CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB View
0.01 0.39 Å 7BEI.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB View
0.01 0.37 Å 7KN6.pdb A H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3 View
0.01 0.37 Å 6ZDH.pdb B F SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.02 0.52 Å 7NDC.pdb B H EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 View
0.05 0.81 Å 7CZU.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B View
0.01 0.45 Å 6XC7.pdb A C CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 View
0.01 0.32 Å 6ZDG.pdb D G ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.0 0.56 Å 7CZY.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B View
0.11 0.9 Å 7LAB.pdb B Y STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 View
0.01 0.34 Å 7NXA.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.03 0.6 Å 7KFW.pdb E F STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) View
0.01 0.42 Å 7KKL.pdb A B SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 View
0.34 1.23 Å 7LQW.pdb C H CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 2-17 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE View
0.03 0.71 Å 7CZV.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B View
0.02 0.45 Å 7LY2.pdb J M SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.01 0.54 Å 7LXZ.pdb B M SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.03 0.56 Å 7D0B.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_1B View
0.01 0.43 Å 6ZDH.pdb C I SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.03 0.54 Å 7ND5.pdb B L EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 150 FAB View
0.01 0.39 Å 6ZDG.pdb A B ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.03 0.55 Å 7KN6.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3 View
0.0 0.66 Å 7DEO.pdb B C CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV View
0.01 0.33 Å 7KML.pdb C J CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND View
0.07 0.73 Å 7CZR.pdb A K S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B View
0.03 0.48 Å 7KMG.pdb C A LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.01 0.33 Å 7NX8.pdb E H CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.0 0.29 Å 7M3I.pdb R L STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB View
0.01 0.46 Å 7A5R.pdb A I COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) View
0.04 0.44 Å 7K8Z.pdb C N STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 View
0.01 0.4 Å 7L0N.pdb S M CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.0 0.39 Å 7M7W.pdb R F ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.08 0.55 Å 7LXY.pdb J N SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.13 0.99 Å 7K8S.pdb B O STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.01 0.32 Å 7M7W.pdb R L ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE View
0.01 0.47 Å 7LXY.pdb J M SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.03 0.71 Å 6XCN.pdb E F STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) View
0.01 0.51 Å 7EAM.pdb B C IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 View
0.01 0.51 Å 7CZS.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B View
0.01 0.37 Å 7NX6.pdb E H CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.02 0.58 Å 7KFW.pdb B C STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) View
0.03 0.54 Å 7K8Y.pdb B G STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2) View
0.03 0.88 Å 7DEO.pdb D C CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV View
0.05 0.56 Å 6XE1.pdb E L STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A POTENT NEUTRALIZING ANTIBODY, CV30 FAB View
0.01 0.72 Å 7CZW.pdb A L S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 View
0.02 0.5 Å 7KFV.pdb A H STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) View
0.02 0.55 Å 6XKP.pdb B H CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 View
0.06 0.67 Å 7K8M.pdb E B STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102 View
0.05 0.26 Å 7JVC.pdb B D SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.05 0.55 Å 7CWU.pdb A O SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.01 0.28 Å 7L3N.pdb B E SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555 View
0.1 0.94 Å 7LXZ.pdb A H SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.03 0.62 Å 7DEO.pdb B A CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV View
0.09 0.76 Å 6W41.pdb C L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022 View
0.01 0.65 Å 7A5R.pdb B M COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) View
0.01 0.38 Å 7DPM.pdb F D CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.01 0.42 Å 7NX7.pdb E L CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.0 0.43 Å 7BEN.pdb C F CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.02 0.38 Å 7KMK.pdb B M CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND View
0.01 0.32 Å 7BEN.pdb C G CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS View
0.09 0.83 Å 7LOP.pdb A L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.0 0.36 Å 7LSS.pdb B H CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 7 View
0.04 0.76 Å 7CHH.pdb B G CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS View
0.08 0.59 Å 7LXY.pdb B G SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT View
0.01 0.38 Å 6XC4.pdb Z X CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 View
0.02 0.72 Å 7LOP.pdb Z W CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.04 0.6 Å 7K8W.pdb A L STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 View
0.08 0.43 Å 7JV4.pdb A H SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN) View
0.03 0.6 Å 6XCM.pdb C H STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) View
0.01 0.46 Å 7NX9.pdb E B CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.06 0.68 Å 7CZS.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B View
0.02 0.42 Å 7K8M.pdb E A STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102 View
0.03 0.84 Å 7CZP.pdb A H S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 View
0.0 0.91 Å 7C01.pdb A D MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD View
0.03 0.49 Å 7K9Z.pdb E L CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 View
0.03 0.49 Å 7CWN.pdb A F P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN View
0.04 0.85 Å 7CZP.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 View
0.02 0.3 Å 7CAK.pdb A D SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB View
0.01 0.37 Å 7C01.pdb A H MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD View
0.02 0.46 Å 7BEP.pdb C D CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS View
0.02 0.52 Å 7KFX.pdb A H STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-C2 FAB) View
0.03 0.45 Å 7KS9.pdb B L CRYO-EM STRUCTURE OF PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH 910-30 FAB View
0.02 0.5 Å 7KXJ.pdb C J SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC View
0.0 0.58 Å 7CZY.pdb C N S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B View
0.03 0.24 Å 7JW0.pdb A L SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT View
0.05 0.87 Å 6XCM.pdb B N STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) View
0.05 0.68 Å 7CWU.pdb B L SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL View
0.01 0.37 Å 6ZDG.pdb D F ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.09 1.13 Å 7L2C.pdb A H CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD) View
0.01 0.5 Å 7CZZ.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B View
0.05 0.86 Å 7KFV.pdb E G STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) View
0.04 0.6 Å 7KZB.pdb C B POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES View
0.04 0.35 Å 7KMG.pdb C E LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.01 0.57 Å 7CZW.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 View
0.04 0.68 Å 7L2E.pdb C K CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.03 0.68 Å 7CDI.pdb E L CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH RBD View
0.0 0.37 Å 7ND7.pdb C K EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB View
0.0 0.4 Å 7NXA.pdb E B CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS View
0.19 1.36 Å 7LY2.pdb A H SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT View
0.05 0.66 Å 7D0C.pdb C G S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 View
0.01 0.48 Å 7L0N.pdb R H CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View
0.03 0.57 Å 7CH5.pdb R L CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB View
0.01 0.24 Å 6ZDG.pdb D C ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB View
0.02 0.75 Å 7LOP.pdb A W CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.02 0.64 Å 7LAB.pdb C L STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 View
0.02 0.61 Å 7LOP.pdb A B CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 View
0.01 0.6 Å 7D00.pdb C J S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 View
0.01 0.41 Å 7KKL.pdb D F SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 View
0.08 0.73 Å 7K8S.pdb A L STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) View
0.06 0.91 Å 7ND4.pdb B G EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB View
0.01 0.47 Å 7CH4.pdb R H CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-604 FAB View
0.01 0.35 Å 7KMH.pdb C A LY-COV488 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 View
0.11 1.01 Å 7M6H.pdb B D STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 View
0.01 0.47 Å 6ZDH.pdb C G SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB View
0.06 0.89 Å 7D0C.pdb A L S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 View
0.04 0.67 Å 7L2E.pdb B J CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN View
0.01 0.42 Å 7JV2.pdb A H SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING MOTIF AND FAB VARIABLE DOMAINS) View
0.01 0.35 Å 7DPM.pdb I G CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB View
0.09 0.93 Å 7LXZ.pdb K N SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT View
0.0 0.46 Å 6ZER.pdb A B CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB View
0.08 0.73 Å 7KFX.pdb A L STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-C2 FAB) View
0.0 0.41 Å 7CAI.pdb C G SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB View
0.01 0.43 Å 7M3I.pdb R H STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB View
0.02 0.5 Å 7L0N.pdb S F CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY View

Search for analysis with matches in this residues: